Abogen Biosciences
Suzhou · Founded 2019
About Abogen Biosciences
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $1.4B
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2021)
- Website: abogenbio.com
- Phone: (207) 939-1665
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/abogen-biosciences-16782 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.